Biocon Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth 12.79%
- Profit Growth 29.23%
- Ebitda -5.12%
- Net Worth 58.66%
- Total Assets -0.56%
About Biocon Research
Biocon Research Limited (BRL) is a leading Public Limited Indian Non-Government Company incorporated in India on 28 May 2008 and has a history of 16 years and eight months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Kiran Shaw, John Shaw, and Arun Chandavarkar serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100KA2008PLC046583
- Company No.
046583
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 May 2008
- Date of AGM
26 Jul 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Biocon Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiran Shaw  | Director | 28-May-2008 | Current |
John Shaw  | Director | 28-May-2008 | Current |
| Arun Chandavarkar | Director | 28-May-2008 | Current |
Financial Performance of Biocon Research.
Biocon Research Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 12.79% increase. The company also saw a substantial improvement in profitability, with a 29.23% increase in profit. The company's net worth Soared by an impressive increase of 58.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biocon Research?
In 2019, Biocon Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Science Gallery BengaluruKiran Shaw is a mutual person
Mazumdar Shaw Medical FoundationKiran Shaw is a mutual person
Immuneel Therapeutics Private LimitedKiran Shaw is a mutual person
Trent LimitedKiran Shaw is a mutual person
Csep Research FoundationKiran Shaw is a mutual person
Biocon AcademyKiran Shaw is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biocon Research?
Biocon Research has a workforce of 536 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biocon Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocon Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
